Overview

Drug-drug Interaction Study (CKD-501, Ketoconazole)

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect of Ketoconazole on the pharmacokinetic characteristics of CKD-501 in healthy subject.
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Collaborator:
Severance Hospital
Treatments:
Ketoconazole